Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Isaac Teitelbaum

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
56
2025
97
14.310
 Why?
Kidney Failure, Chronic
42
2025
566
7.820
 Why?
Peritonitis
22
2025
84
4.630
 Why?
Renal Dialysis
18
2022
435
2.410
 Why?
Dialysis Solutions
11
2023
21
1.770
 Why?
Peritoneum
6
2023
43
1.150
 Why?
Kidney
8
2023
1467
1.130
 Why?
Sodium
3
2025
216
0.970
 Why?
Hyponatremia
2
2025
42
0.950
 Why?
Serum Albumin
3
2022
150
0.880
 Why?
Kidney Tubules, Collecting
12
1994
31
0.870
 Why?
Peritoneal Dialysis, Continuous Ambulatory
6
2021
15
0.720
 Why?
Catheters, Indwelling
5
2019
91
0.710
 Why?
Acute Kidney Injury
5
2023
809
0.660
 Why?
Staphylococcus capitis
1
2019
1
0.650
 Why?
Coagulase
1
2019
6
0.650
 Why?
Renal Insufficiency, Chronic
3
2015
612
0.620
 Why?
Renal Replacement Therapy
4
2023
92
0.620
 Why?
Ferric Compounds
2
2022
56
0.600
 Why?
Sucrose
2
2022
110
0.600
 Why?
Quality of Health Care
2
2020
634
0.600
 Why?
Catheter-Related Infections
1
2019
90
0.590
 Why?
Anti-Bacterial Agents
6
2024
1797
0.560
 Why?
Arginine Vasopressin
7
1997
44
0.560
 Why?
Hyperphosphatemia
3
2022
15
0.560
 Why?
Kidney Transplantation
3
2012
701
0.550
 Why?
Humans
78
2025
136765
0.540
 Why?
Peritoneal Fibrosis
1
2017
1
0.540
 Why?
Staphylococcal Infections
3
2019
399
0.530
 Why?
Kidney Function Tests
4
2020
159
0.510
 Why?
Uremia
2
2014
16
0.510
 Why?
Glucans
2
2015
24
0.500
 Why?
Patient-Centered Care
1
2020
522
0.480
 Why?
Therapeutics
1
2015
14
0.470
 Why?
Body Water
1
2015
21
0.460
 Why?
Kidney Medulla
10
1997
35
0.460
 Why?
Voriconazole
1
2015
20
0.460
 Why?
beta-Cyclodextrins
1
2015
28
0.460
 Why?
Phosphates
2
2022
182
0.440
 Why?
Catheterization
3
2016
179
0.440
 Why?
Antifungal Agents
1
2015
136
0.440
 Why?
Chelating Agents
1
2014
75
0.420
 Why?
Blood Pressure
1
2020
1774
0.400
 Why?
GTP-Binding Proteins
6
1995
161
0.390
 Why?
Hemodialysis Solutions
1
2012
3
0.390
 Why?
Type C Phospholipases
6
1992
74
0.390
 Why?
Acidosis
1
2013
101
0.370
 Why?
Kidney Diseases
4
2021
407
0.360
 Why?
Hemofiltration
2
2010
30
0.360
 Why?
Glucose
2
2015
1019
0.340
 Why?
Hirudins
1
2010
53
0.340
 Why?
Urea
4
2021
81
0.320
 Why?
Cyclic AMP
6
1995
234
0.320
 Why?
Creatinine
5
2020
499
0.310
 Why?
Protein Kinase C
5
1995
261
0.310
 Why?
Kidney Tubules
4
1990
117
0.310
 Why?
Heparin
1
2010
259
0.300
 Why?
Nutritional Status
4
2022
344
0.300
 Why?
Heart Diseases
1
2012
346
0.300
 Why?
Glomerular Filtration Rate
5
2023
745
0.290
 Why?
Drug Resistance, Bacterial
1
2009
185
0.280
 Why?
Hemodialysis, Home
4
2023
8
0.280
 Why?
Middle Aged
19
2025
33228
0.260
 Why?
Peptide Fragments
1
2010
705
0.260
 Why?
Survivors
1
2010
487
0.250
 Why?
Cardiac Surgical Procedures
1
2012
530
0.250
 Why?
Scleroderma, Systemic
1
2007
122
0.250
 Why?
Patient Selection
2
2020
690
0.240
 Why?
Calcium
4
2020
1197
0.240
 Why?
Hernia, Abdominal
1
2005
6
0.240
 Why?
Postoperative Complications
3
2012
2639
0.240
 Why?
Peritoneal Cavity
1
2005
31
0.240
 Why?
Patient Participation
2
2020
418
0.230
 Why?
Prospective Studies
11
2023
7572
0.230
 Why?
Phosphorus
3
2022
97
0.230
 Why?
Liver Failure
1
2005
94
0.220
 Why?
Time Factors
6
2015
6808
0.220
 Why?
Internationality
3
2020
154
0.220
 Why?
Hemoglobins
2
2020
353
0.220
 Why?
Aged
14
2025
23794
0.220
 Why?
Liver Transplantation
2
2012
871
0.220
 Why?
Teicoplanin
1
2024
15
0.210
 Why?
Practice Patterns, Physicians'
2
2025
1301
0.210
 Why?
Quality Improvement
2
2023
1163
0.210
 Why?
Male
24
2025
67311
0.210
 Why?
Blood Chemical Analysis
1
2003
99
0.200
 Why?
Quality of Life
5
2020
2878
0.200
 Why?
Practice Guidelines as Topic
3
2020
1571
0.190
 Why?
Device Removal
2
2019
136
0.190
 Why?
Female
23
2025
72795
0.190
 Why?
Phosphatidylinositols
3
1991
57
0.190
 Why?
Rats
13
2014
5639
0.190
 Why?
Contraindications, Procedure
1
2021
11
0.190
 Why?
Goals
2
2020
169
0.180
 Why?
Nephrologists
1
2021
13
0.180
 Why?
Attitude of Health Personnel
2
2020
1163
0.180
 Why?
Organism Hydration Status
1
2020
9
0.180
 Why?
Critical Illness
4
2023
804
0.170
 Why?
Superior Vena Cava Syndrome
1
2000
3
0.170
 Why?
Chylous Ascites
1
2000
6
0.170
 Why?
Epidermal Growth Factor
6
1994
175
0.170
 Why?
Acid-Base Equilibrium
1
2020
28
0.170
 Why?
Liver Cirrhosis
1
2003
316
0.170
 Why?
Stress, Psychological
1
2009
1097
0.170
 Why?
Risk Factors
7
2023
10325
0.170
 Why?
Treatment Outcome
9
2020
10745
0.170
 Why?
Blood Volume
1
2020
61
0.170
 Why?
Magnesium
1
2020
156
0.160
 Why?
Patient Care Planning
1
2020
157
0.160
 Why?
Potassium
1
2020
147
0.160
 Why?
Cohort Studies
5
2025
5701
0.160
 Why?
Patient Reported Outcome Measures
2
2020
402
0.160
 Why?
Physician Executives
1
2019
31
0.150
 Why?
Congresses as Topic
1
2020
232
0.140
 Why?
Dogs
2
2023
411
0.140
 Why?
Drug Combinations
2
2022
343
0.140
 Why?
Societies, Medical
2
2020
816
0.140
 Why?
Survival Rate
2
2020
1963
0.140
 Why?
Receptors, Vasopressin
2
1995
20
0.140
 Why?
Kidney Concentrating Ability
1
1997
3
0.140
 Why?
Renal Insufficiency
1
2020
155
0.140
 Why?
Patient Education as Topic
3
2018
761
0.140
 Why?
Adenylyl Cyclase Inhibitors
2
1994
8
0.140
 Why?
Data Collection
1
2020
668
0.140
 Why?
Risk Assessment
4
2016
3432
0.140
 Why?
Adenylyl Cyclases
3
1993
87
0.130
 Why?
Adult
18
2024
37631
0.130
 Why?
United States
7
2023
14690
0.130
 Why?
Proportional Hazards Models
3
2022
1261
0.130
 Why?
Survival Analysis
2
2015
1321
0.120
 Why?
Hormones
2
1994
142
0.120
 Why?
Models, Animal
1
2017
384
0.120
 Why?
Ultrafiltration
1
2015
28
0.120
 Why?
Epithelial-Mesenchymal Transition
1
2017
209
0.110
 Why?
Curriculum
1
2021
975
0.110
 Why?
Kaplan-Meier Estimate
2
2015
888
0.110
 Why?
Gastrointestinal Absorption
1
2014
5
0.110
 Why?
Lung Injury
1
2017
218
0.110
 Why?
Diglycerides
2
1993
61
0.110
 Why?
Palliative Care
1
2020
752
0.110
 Why?
Inflammation
3
2017
2835
0.110
 Why?
Virulence Factors, Bordetella
2
1991
20
0.110
 Why?
Pertussis Toxin
2
1991
26
0.110
 Why?
Treatment Failure
1
2015
354
0.110
 Why?
Biological Transport
1
2015
416
0.110
 Why?
Didanosine
1
1993
13
0.110
 Why?
Phospholipases A
2
1992
102
0.100
 Why?
Anti-Infective Agents
1
2016
254
0.100
 Why?
Animals
17
2023
36847
0.100
 Why?
Cytosol
1
1994
226
0.100
 Why?
Biomedical Research
1
2020
688
0.100
 Why?
HIV Seropositivity
1
1993
125
0.100
 Why?
Oleanolic Acid
1
2012
9
0.100
 Why?
Methylene Blue
1
2012
23
0.100
 Why?
Equipment Design
2
2014
521
0.100
 Why?
Tissue Adhesions
1
2012
32
0.100
 Why?
Vascular Calcification
1
2014
108
0.100
 Why?
Delayed Graft Function
1
2012
33
0.090
 Why?
Hematinics
1
2012
22
0.090
 Why?
Prognosis
4
2016
4013
0.090
 Why?
Cells, Cultured
9
1994
4191
0.090
 Why?
Receptors, Angiotensin
1
1991
12
0.090
 Why?
Vasoconstrictor Agents
1
2012
139
0.090
 Why?
Nephrectomy
1
2012
168
0.090
 Why?
Transplantation, Homologous
1
2012
415
0.090
 Why?
Atrial Natriuretic Factor
1
1991
57
0.090
 Why?
Retrospective Studies
6
2023
15504
0.090
 Why?
Hypotension
1
2012
122
0.090
 Why?
Restless Legs Syndrome
1
2011
21
0.090
 Why?
Bacterial Infections
2
2003
250
0.090
 Why?
Glycerides
1
1990
21
0.080
 Why?
Aluminum Compounds
1
1990
5
0.080
 Why?
Phospholipases
1
1990
14
0.080
 Why?
Antithrombins
1
2010
60
0.080
 Why?
Membranes, Artificial
1
2010
72
0.080
 Why?
Follow-Up Studies
4
2011
5106
0.080
 Why?
Virginiamycin
1
2009
3
0.080
 Why?
Models, Biological
1
2017
1773
0.080
 Why?
Linezolid
1
2009
20
0.080
 Why?
Daptomycin
1
2009
18
0.080
 Why?
Oxazolidinones
1
2009
15
0.080
 Why?
Graft Survival
1
2012
534
0.080
 Why?
Double-Blind Method
2
2012
1981
0.080
 Why?
Minerals
1
2009
42
0.080
 Why?
Acetamides
1
2009
36
0.080
 Why?
Protein Kinases
1
1991
319
0.080
 Why?
Enzyme Inhibitors
1
2012
839
0.070
 Why?
Infection Control
1
2010
165
0.070
 Why?
Antibiotic Prophylaxis
2
2022
115
0.070
 Why?
Hematuria
1
1988
12
0.070
 Why?
Communicable Diseases
1
2010
159
0.070
 Why?
Sympathetic Nervous System
1
1989
182
0.070
 Why?
Enzyme Activation
4
1994
810
0.070
 Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
 Why?
Hepatorenal Syndrome
1
2007
16
0.070
 Why?
Proteinuria
1
1988
97
0.070
 Why?
Aged, 80 and over
1
2019
7585
0.070
 Why?
Sleep Wake Disorders
1
2011
283
0.070
 Why?
Tetradecanoylphorbol Acetate
3
1993
150
0.070
 Why?
RNA, Messenger
1
1995
2831
0.070
 Why?
Recombinant Proteins
1
2010
1350
0.070
 Why?
Spondylitis, Ankylosing
1
1988
46
0.070
 Why?
Primary Prevention
2
2016
196
0.070
 Why?
Inositol Phosphates
3
1991
22
0.070
 Why?
ErbB Receptors
1
1990
613
0.060
 Why?
Biopsy, Needle
1
2007
189
0.060
 Why?
Anticoagulants
1
2010
663
0.060
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
 Why?
Nephrology
2
2020
61
0.060
 Why?
Incidence
3
2007
2792
0.060
 Why?
Imipenem
1
2005
18
0.060
 Why?
Ethics, Clinical
1
2005
7
0.060
 Why?
Medication Adherence
1
2009
466
0.060
 Why?
Kinetics
3
2017
1664
0.060
 Why?
Skin Diseases
1
2007
149
0.060
 Why?
Vasculitis
1
2005
66
0.060
 Why?
Capillaries
1
2005
108
0.060
 Why?
Staphylococcus aureus
1
2009
449
0.060
 Why?
Fibrosis
1
2007
551
0.050
 Why?
Gastric Acid
1
2023
14
0.050
 Why?
Canada
1
2005
417
0.050
 Why?
Bromcresol Green
1
2003
1
0.050
 Why?
Bromcresol Purple
1
2003
1
0.050
 Why?
Nephelometry and Turbidimetry
1
2003
13
0.050
 Why?
Health Services Accessibility
1
2011
977
0.050
 Why?
Combined Modality Therapy
1
2007
1231
0.050
 Why?
Hepcidins
1
2023
22
0.050
 Why?
Indicators and Reagents
1
2003
106
0.050
 Why?
Triglycerides
1
2006
524
0.050
 Why?
Permeability
1
2003
161
0.050
 Why?
Equipment Failure
1
2003
108
0.050
 Why?
Drug Resistance
2
2012
169
0.050
 Why?
Disease Models, Animal
1
2014
4282
0.050
 Why?
Vancomycin
1
2024
81
0.050
 Why?
Eosinophils
1
2006
332
0.050
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
21
0.050
 Why?
Severity of Illness Index
2
2011
2822
0.050
 Why?
Monocytes
1
2006
563
0.050
 Why?
Regression Analysis
1
2005
1022
0.050
 Why?
Cats
1
2023
209
0.050
 Why?
Hypoalbuminemia
1
2022
30
0.050
 Why?
Burns
1
2007
325
0.050
 Why?
Medicare
2
2022
758
0.050
 Why?
Lung Transplantation
1
2005
313
0.050
 Why?
Ownership
1
2023
93
0.050
 Why?
Phospholipases A2
2
1992
80
0.050
 Why?
Patient Compliance
1
2006
577
0.050
 Why?
Positron-Emission Tomography
1
2023
293
0.040
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
14
0.040
 Why?
Guanosine Diphosphate
2
1991
20
0.040
 Why?
Thionucleotides
2
1991
35
0.040
 Why?
Erythrocytes
1
2006
699
0.040
 Why?
Dinoprostone
2
1990
191
0.040
 Why?
Recurrence
1
2003
1055
0.040
 Why?
Chronic Disease
1
2005
1785
0.040
 Why?
Terminology as Topic
1
2020
216
0.040
 Why?
Child
3
2013
21819
0.040
 Why?
Potassium, Dietary
1
1998
12
0.040
 Why?
Drinking
1
1998
42
0.040
 Why?
Predictive Value of Tests
2
2017
2022
0.040
 Why?
Sodium, Dietary
1
1998
41
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2518
0.030
 Why?
Cardiovascular Diseases
1
2010
2104
0.030
 Why?
Pilot Projects
1
2022
1692
0.030
 Why?
Diabetic Nephropathies
1
2000
294
0.030
 Why?
Quality Control
1
2017
171
0.030
 Why?
Dose-Response Relationship, Drug
2
1991
2052
0.030
 Why?
Hospitalization
1
2006
2182
0.030
 Why?
Fluid Therapy
1
2017
147
0.030
 Why?
Reproducibility of Results
1
2003
3265
0.030
 Why?
Prostaglandins
1
1995
97
0.030
 Why?
Ionomycin
1
1994
23
0.030
 Why?
Quality Indicators, Health Care
1
2017
307
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
182
0.030
 Why?
Isoproterenol
1
1994
113
0.030
 Why?
Prevalence
2
2011
2710
0.030
 Why?
Colforsin
1
1993
53
0.030
 Why?
Guanylate Cyclase
1
1992
37
0.020
 Why?
Shock, Surgical
1
2012
1
0.020
 Why?
Interleukin-6
1
2017
778
0.020
 Why?
Intraoperative Care
1
2012
49
0.020
 Why?
Catecholamines
1
2012
98
0.020
 Why?
Poisson Distribution
1
2012
73
0.020
 Why?
Sample Size
1
2012
125
0.020
 Why?
Prospective Payment System
1
2011
14
0.020
 Why?
Base Sequence
1
1995
2179
0.020
 Why?
Total Quality Management
1
2011
61
0.020
 Why?
Inositol
1
1991
26
0.020
 Why?
Accreditation
1
2011
82
0.020
 Why?
Receptors, Oxytocin
1
1991
23
0.020
 Why?
Cyclic GMP
1
1991
93
0.020
 Why?
Dideoxyadenosine
1
1990
3
0.020
 Why?
Oxytocin
1
1991
51
0.020
 Why?
Molecular Sequence Data
1
1995
2894
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
28
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
7
0.020
 Why?
Isoquinolines
1
1990
42
0.020
 Why?
Fluorides
1
1990
49
0.020
 Why?
Guanosine Triphosphate
1
1990
91
0.020
 Why?
Aluminum
1
1990
42
0.020
 Why?
Hydrolysis
1
1990
176
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2486
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
28
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
34
0.020
 Why?
Analysis of Variance
1
2012
1316
0.020
 Why?
Health Surveys
1
2011
513
0.020
 Why?
Rats, Inbred Strains
1
1989
362
0.020
 Why?
In Vitro Techniques
1
1990
1089
0.020
 Why?
Adrenergic beta-Agonists
1
1989
133
0.020
 Why?
Glomerulonephritis, IGA
1
1988
11
0.020
 Why?
Piperazines
1
1990
350
0.020
 Why?
Clinical Trials as Topic
1
2012
1044
0.020
 Why?
Cost of Illness
1
2009
302
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
323
0.020
 Why?
Morbidity
1
2007
323
0.020
 Why?
Cilastatin
1
2005
2
0.020
 Why?
Research Design
1
2012
1127
0.020
 Why?
Biomarkers
1
2017
4144
0.010
 Why?
Hemodiafiltration
1
2005
9
0.010
 Why?
Multivariate Analysis
1
2009
1507
0.010
 Why?
Healthcare Disparities
1
2012
649
0.010
 Why?
Osmolar Concentration
2
1998
171
0.010
 Why?
Telemedicine
1
2014
851
0.010
 Why?
Protease Inhibitors
1
2005
107
0.010
 Why?
Sensitivity and Specificity
1
2009
1935
0.010
 Why?
Biopsy
1
1988
1124
0.010
 Why?
Protein Kinase Inhibitors
1
1990
916
0.010
 Why?
Comorbidity
1
2009
1614
0.010
 Why?
Acute Disease
1
2007
1006
0.010
 Why?
Respiratory Function Tests
1
2005
595
0.010
 Why?
Drug Therapy, Combination
1
2005
1062
0.010
 Why?
Graft Rejection
1
2005
620
0.010
 Why?
Immunosuppressive Agents
1
2005
889
0.010
 Why?
Colorado
1
1990
4515
0.010
 Why?
Mice
1
2017
17757
0.010
 Why?
Lung Diseases
1
2005
768
0.010
 Why?
Diet, Vegetarian
1
1998
8
0.010
 Why?
Beer
1
1998
12
0.010
 Why?
Urine
1
1998
56
0.010
 Why?
Cross-Sectional Studies
1
2009
5423
0.010
 Why?
Dietary Proteins
1
1998
135
0.010
 Why?
Signal Transduction
1
1990
5076
0.010
 Why?
Muscarine
1
1994
3
0.010
 Why?
Carbachol
1
1994
20
0.010
 Why?
Vasopressins
1
1994
64
0.010
 Why?
Tyrosine
1
1994
222
0.010
 Why?
Cell Polarity
1
1994
141
0.010
 Why?
Purines
1
1994
176
0.010
 Why?
Adolescent
1
2012
21382
0.010
 Why?
Lung
1
2005
4062
0.010
 Why?
Hypertonic Solutions
1
1991
7
0.010
 Why?
Nocodazole
1
1991
16
0.010
 Why?
Cycloheximide
1
1991
55
0.010
 Why?
Isotonic Solutions
1
1991
38
0.010
 Why?
Culture Media
1
1991
165
0.010
 Why?
Phosphorylation
1
1994
1758
0.010
 Why?
Peptides
1
1994
980
0.000
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)